Publications
Publications
Show Results For
-
All HBS Web
(23,996)
- Faculty Publications (1,099)
Page 1 of
1,099
Results
→
Are you looking for?
A collective of featured works, most recent HBS publications, and the School's approach
to research on the topic of health care.
Skip to Main Content HBS Home About Academic Programs Alumni Faculty & Research Baker Library Giving Harvard Business Review Initiatives News Recruit...
- January 2021
- Case
Value-Based Insurance Design at Onex
By: Joshua Schwartzstein, Amitabh Chandra and Amram Migdal
The operating executives of Health and Benefits for Onex Partners, Megan Jackson Frye and Sam Camens, faced a challenge: Healthcare costs for employees of Onex’s portfolio companies were continuing to rise above the consumer price index, reflecting broader trends...
View Details
Keywords:
Decision Making;
Cost Vs Benefits;
Decision Choices And Conditions;
Decisions;
Finance;
Behavioral Finance;
Insurance;
health;
health care And Treatment;
Human Resources;
Compensation And Benefits;
Markets;
Demand And Consumers;
Consumer Behavior;
Social Psychology;
Behavior;
Interests;
Motivation And Incentives;
Perception;
health Industry;
Insurance Industry;
North America;
United States
- January–February 2021
- Article
Food and Drug Administration Guidance Documents and New Medical Devices: The Case of Breast Prostheses
By: Rachel E. Weitzman, Ariel Dora Stern and Daniel B. Kramer
As pressure mounts on the Food and Drug Administration (FDA) to speed its review process for novel devices, and budgetary pressures further strain its resources, the critical role of guidance documents in assuring consistent, rigorous, and scientifically grounded...
View Details
- January 2021
- Article
COVID-19 Hasn't Been a Tipping Point for Value-Based Care, but It Should Be
By: Thomas W. Feeley
Four out of five health care provider organizations are suffering ongoing losses as a result of the
COVID-19 pandemic, according to the recent NEJM Catalyst Insights Council survey on value-based
payment and care. Yet Council members, who are still largely entrenched...
View Details
- December 2020
- Case
IBM Watson at MD Anderson Cancer Center
By: Shane Greenstein, Mel Martin and Sarkis Agaian
After discovering that their cancer diagnostic tool, designed to leverage the cloud computing power of IBM Watson, needed greater integration into the clinical processes at the MD Anderson Cancer Center, the development team had difficult choices to make. The Oncology...
View Details
Keywords:
Decision Making;
Innovation Strategy;
Knowledge Management;
Knowledge Use And Leverage;
Operations;
Failure;
Technology;
Information Technology;
Software;
health care And Treatment;
Product Development;
health Industry;
Information Technology Industry;
Technology Industry;
United States;
Houston;
Texas
- Article
Want to See the Future of Digital Health Tools? Look to Germany
By: Ariel Dora Stern, Henrik Matthies, Julia Hagen, Jan B. Brönneke and Jörg F. Debatin
A new law will make it easier to introduce and determine the benefits of new tools. Perhaps its most important provisions are its formalization of “prescribable applications,” which include standard software, SaaS, and mobile as well as browser-based apps, and the...
View Details
- Article
Value of New Performance Information in Healthcare: Evidence from Japan
By: Susanna Gallani, Takehisa Kajiwara and Ranjani Krishnan
Mandatory measurement and disclosure of outcome measures are commonly used policy tools in
healthcare. The effectiveness of such disclosures relies on the extent to which the new information produced by the mandatory system is internalized by the healthcare...
View Details
- November 24, 2020
- Article
4 Strategies to Make Telehealth Work for Elderly Patients
By: Umar Ikram, Susanna Gallani, Jose F. Figueroa and Thomas W. Feeley
As providers have ramped up their use of telehealth during the COVID-19 pandemic, one group—the elderly—has experienced particular challenges in adopting the technologies. This article describes the strategies four innovative provider organizations have used to engage...
View Details
- November 2020
- Case
Roll-Ups and Surprise Billing: Collisions at the Intersection of Private Equity and Patient Care
By: Trevor Fetter and Kira Seiger
This case describes the increasing investment by private equity (PE) firms in patient care and other healthcare services. The case focuses on investments in physician staffing firms and roll-up strategy investments in physician practice management (PPM). Included in...
View Details
Keywords:
Business Ventures;
Acquisition;
Mergers And Acquisitions;
Business Model;
Change;
Disruption;
Fluctuation;
Trends;
Customers;
Customer Value And Value Chain;
Ethics;
Fairness;
Finance;
Equity;
Insurance;
Private Equity;
Geography;
Geographic Scope;
health;
health care And Treatment;
Markets;
Demand And Consumers;
Supply And Industry;
Industry Structures;
Ownership;
Ownership Type;
Private Ownership;
Relationships;
Agency Theory;
Business And Community Relations;
Business And Shareholder Relations;
Business And Stakeholder Relations;
Networks;
Strategy;
Competition;
Consolidation;
Expansion;
Integration;
Horizontal Integration;
Vertical Integration;
Value;
Value Creation;
health Industry;
Insurance Industry;
United States
- 2020
- Working Paper
Hospital Allocation and Racial Disparities in Health Care
By: Amitabh Chandra, Pragya Kakani and Adam Sacarny
We develop a simple framework to measure the role of hospital allocation in racial disparities in health care and use it to study Black and white Medicare patients who are treated for heart attacks—a condition where virtually everyone receives care, hospital care is...
View Details
- October 2020
- Case
Michael Phelps: 'It's Okay to Not Be Okay'
By: Boris Groysberg, Carin-Isabel Knoop and Michael Norris
In 2020, Michael Phelps, the most decorated Olympian of all time, with 28 medals in various swimming events, was now retired. As he looked back on his 20+ year athletic career, he considered what had gone into making him the greatest of all time—the highs and lows,...
View Details
- October 2020
- Case
COVID-19 Testing at Everlywell
By: Jeffrey J. Bussgang and Olivia Hull
In March 2020, as COVID-19 spreads rapidly across the U.S., Everlywell founder Julia Cheek considers how to respond as a small start-up specializing in at-home lab testing. After making dramatic budget cuts, she decides to pivot the organization to address the...
View Details
Keywords:
Entrepreneurship;
Business Strategy;
Venture Capital;
health care And Treatment;
health Disorders;
Leading Change;
Technology Adoption;
Technology Platform;
Competitive Strategy;
Science;
Adaptation;
Corporate Social Responsibility And Impact;
Crisis Management;
Social Entrepreneurship;
Ethics;
Government Legislation;
health;
health Testing And Trials;
health Pandemics;
Consumer Products Industry;
health Industry;
Technology Industry;
Texas;
United States
- October 2020
- Article
Task Selection and Workload: A Focus on Completing Easy Tasks Hurts Long-Term Performance
By: Diwas S. KC, Bradley R. Staats, Maryam Kouchaki and Francesca Gino
How individuals manage, organize, and complete their tasks is central to operations management. Recent research in operations focuses on how under conditions of increasing workload individuals can decrease their service time, up to a point, in order to complete work...
View Details
- September 2020
- Case
Enabling Teamwork at the Cleveland Clinic
By: Amy C. Edmondson and Michaela J. Kerrissey
This case examines efforts to foster teamwork within and across work units in the Cleveland Clinic, a large, distributed healthcare delivery organization. With a long history of valuing teamwork since its founding in 1921, the Clinic had taken dramatic steps to further...
View Details
- September 2020
- Case
Walmart Health: Scaling During a Pandemic
By: Robert S. Huckman, Yoonjin Min and Marissa Thiel
Amidst the onset of COVID-19 pandemic in the United States, Marcus Obsborne, Vice President for Health and Wellness Transformation at Walmart was planning to scale its new health care clinic business, Walmart Health, to additional locations in Georgia and beyond....
View Details
- September 8, 2020
- Article
Allocation of COVID-19 Relief Funding to Disproportionately Black Counties
By: Pragya Kakani, Amitabh Chandra and Sendhil Mullainathan
This study describes correlations between the dollar amount of relief funding authorized by the US Congress to fund prevention, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) and to reimburse health care entities for lost revenues, and county-level...
View Details
- 8 Sep 2020
- Interview
The U.S. Health Care System: From Dysfunction to Functioning
By: Regina E. Herzlinger and Edward Shin
- September 2, 2020
- Article
How to Pay for Public Option Without Tax Hike
By: Regina E. Herzlinger and Richard Boxer
A “Public Option” for health insurance that uses Medicare provider pricing and is administered by private insurers whose overall pricing conforms to GAAP will attain important, bi-partisan goals. For the Democrats, its lower costs will enable enrollment of the...
View Details
- 2020
- Working Paper
Chimeric Antigen Receptor (CAR) T-Cell Therapy: Case Histories of Significant Medical Advances
By: Amar Bhidé and Srikant M. Datar
In 2017, the US Food and Drug Administration (FDA) approved an immunotherapeutic treatment, called CAR-T therapy, for two kinds of blood cancers—acute leukemia (ALL) and a lymphoma. We describe 1) how CAR-T works; 2) the foundational advances and discoveries; 3)...
View Details
- September 2020
- Article
Regulatory Sandboxes: A Cure for mHealth Pilotitis?
By: Abhishek Bhatia, Rahul Matthan, Tarun Khanna and Satchit Balsari
Mobile health (mHealth) and related digital health interventions in the past decade have not always scaled globally as anticipated earlier despite large investments by governments and philanthropic foundations. The implementation of digital health tools has suffered...
View Details
- September–October 2020
- Article
The Past, Present, and (Near) Future of Gene Therapy and Gene Editing
By: Julia Pian, Amitabh Chandra and Ariel Dora Stern
Emerging gene therapy and gene-editing technologies will have a growing impact on patient lives and health-care delivery. We analyzed a decade of data on clinical trials and venture capital investments to understand the likely trajectory of genetically focused...
View Details